Cedillo L, Ahsan FM, Li S, et al. Ether lipid biosynthesis promotes lifespan extension and enables diverse pro-longevity paradigms in . eLife. 2023;12. doi:10.7554/eLife.82210PubMedDOIGoogle Scholar
Dou Y, Katsnelson L, Gritsenko MA, et al. Proteogenomic insights suggest druggable pathways in endometrial carcinoma. Cancer cell. 2023. doi:10.1016/j.ccell.2023.07.007PubMedDOIGoogle Scholar
Billings LK, Jablonski KA, Warner S, et al. Variation in Maturity-Onset Diabetes of the Young Genes Influence Response to Interventions for Diabetes Prevention. J Clin Endocrinol Metab. 2017;102(8):2678-2689. doi:10.1210/jc.2016-3429DOIGoogle ScholarPubMed
Florez JC. The pharmacogenetics of metformin. Diabetologia. 2017;60(9):1648-1655. doi:10.1007/s00125-017-4335-yPubMedDOIGoogle Scholar
Srinivasan S, Kaur V, Chamarthi B, et al. Genetic Variation Augments Incretin Resistance and Influences Response to a Sulfonylurea and Metformin: The Study to Understand the Genetics of the Acute Response to Metformin and Glipizide in Humans (SUGAR-MGH). Diabetes Care. 2018;41(3):554-561. doi:10.2337/dc17-1386PubMedDOIGoogle Scholar
Birsoy K, Sabatini DM, Possemato R. Untuning the tumor metabolic machine: Targeting cancer metabolism: a bedside lesson. Nat Med. 2012;18(7):1022-3. doi:10.1038/nm.2870PubMedDOIGoogle Scholar
Florez JC, Jablonski KA, McAteer JB, et al. Effects of genetic variants previously associated with fasting glucose and insulin in the Diabetes Prevention Program. PLoS One. 2012;7(9):e44424. doi:10.1371/journal.pone.0044424PubMedDOIGoogle Scholar
Pawlyk AC, Giacomini KM, McKeon C, Shuldiner AR, Florez JC. Metformin pharmacogenomics: current status and future directions. Diabetes. 2014;63(8):2590-9. doi:10.2337/db13-1367PubMedDOIGoogle Scholar
Walford GA, Davis J, Warner S, et al. Branched chain and aromatic amino acids change acutely following two medical therapies for type 2 diabetes mellitus. Metabolism. 2013;62(12):1772-8. doi:10.1016/j.metabol.2013.07.003PubMedDOIGoogle Scholar
Walford GA, Colomo N, Todd JN, et al. The study to understand the genetics of the acute response to metformin and glipizide in humans (SUGAR-MGH): design of a pharmacogenetic resource for type 2 diabetes. PLoS One. 2015;10(3):e0121553. doi:10.1371/journal.pone.0121553DOIGoogle ScholarPubMed